137 related articles for article (PubMed ID: 34927515)
1. Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis.
Negoro H; Chatziantonio C; Razzaque MS
Expert Rev Anti Infect Ther; 2022 May; 20(5):657-661. PubMed ID: 34927515
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1.
Nishio Y; Fujino M; Zhao M; Ishii T; Ishizuka M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Taketani S; Nagahara Y; Li XK
Int Immunopharmacol; 2014 Apr; 19(2):300-7. PubMed ID: 24530569
[TBL] [Abstract][Full Text] [Related]
3. Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro.
Nara E; Lai HW; Imazato H; Ishizuka M; Nakajima M; Ogura SI
PLoS One; 2023; 18(2):e0281399. PubMed ID: 36757984
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases.
Shimura M; Nozawa N; Ogawa-Tominaga M; Fushimi T; Tajika M; Ichimoto K; Matsunaga A; Tsuruoka T; Kishita Y; Ishii T; Takahashi K; Tanaka T; Nakajima M; Okazaki Y; Ohtake A; Murayama K
Sci Rep; 2019 Jul; 9(1):10549. PubMed ID: 31332208
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron.
Ito H; Nishio Y; Hara T; Sugihara H; Tanaka T; Li XK
Eur J Pharmacol; 2018 Aug; 833():25-33. PubMed ID: 29753693
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death-ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model.
Hu X; Que W; Hirano H; Wang Z; Nozawa N; Ishii T; Ishizuka M; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Guo WZ; Li XK
Cancer Sci; 2021 Jul; 112(7):2652-2663. PubMed ID: 33934440
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminolevulinic acid with sodium ferrous citrate induces autophagy and protects cardiomyocytes from hypoxia-induced cellular injury through MAPK-Nrf-2-HO-1 signaling cascade.
Zhao M; Zhu P; Fujino M; Nishio Y; Chen J; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhao L; Zhuang J; Li XK
Biochem Biophys Res Commun; 2016 Oct; 479(4):663-669. PubMed ID: 27693692
[TBL] [Abstract][Full Text] [Related]
8. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
Liu C; Wang Z; Hu X; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Li XK
Int Immunopharmacol; 2021 Jul; 96():107626. PubMed ID: 33862551
[TBL] [Abstract][Full Text] [Related]
9. Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: Study protocol for clinical trial (SPIRIT compliant).
Sumiyoshi R; Koga T; Shimizu T; Sato S; Tashiro S; Hosogaya N; Yamamoto H; Kawakami A
Medicine (Baltimore); 2020 Dec; 99(50):e22708. PubMed ID: 33327226
[TBL] [Abstract][Full Text] [Related]
10. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.
Zhao M; Guo H; Chen J; Fujino M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Wang J; Huang H; Zheng S; Hei M; Li J; Huang S; Li J; Ma X; Chen Y; Zhao L; Zhuang J; Zhu P; Li XK
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C665-72. PubMed ID: 25652453
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction.
Fujino M; Nishio Y; Ito H; Tanaka T; Li XK
Int Immunopharmacol; 2016 Aug; 37():71-78. PubMed ID: 26643355
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2.
Ngwe Tun MM; Sakura T; Sakurai Y; Kurosaki Y; Inaoka DK; Shioda N; Yasuda J; Kita K; Morita K
Trop Med Health; 2022 Jan; 50(1):6. PubMed ID: 34991723
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial.
Tanaka T; Tashiro M; Ota K; Fujita A; Sawai T; Kadota J; Fukuda Y; Sumiyoshi M; Ide S; Tachikawa N; Fujii H; Hibino M; Shiomi H; Izumida M; Matsui K; Yamauchi M; Takahashi K; Yamanashi H; Sugimoto T; Akabame S; Umeda M; Shimizu M; Hosogaya N; Kosai K; Takeda K; Iwanaga N; Ashizawa N; Hirayama T; Takazono T; Yamamoto K; Imamura Y; Miyazaki T; Kobayashi Y; Ariyoshi K; Mukae H; Yanagihara K; Kita K; Izumikawa K
Medicine (Baltimore); 2023 Aug; 102(34):e34858. PubMed ID: 37653769
[TBL] [Abstract][Full Text] [Related]
14. 5-ALA/SFC Attenuated Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats.
Liu C; Zhu P; Fujino M; Zhu S; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhuang J; Li XK
Alcohol Clin Exp Res; 2019 Aug; 43(8):1651-1661. PubMed ID: 31141180
[TBL] [Abstract][Full Text] [Related]
15. Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease.
Liu C; Yang X; Zhu P; Fujino M; Ito H; Takahashi K; Nakajima M; Tanaka T; Wang J; Zhuang J; Zou H; Li XK
Exp Dermatol; 2018 Oct; 27(10):1104-1111. PubMed ID: 29978518
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer.
Kawamura K; Matsushima H; Sakai H; Iwashima A; Nakamura S; Kojima T; Sasaki S; Shigenaga T; Natsume I; Sasaki T; Ohsaki Y; Iwanaga K; Nishi K; Mitsuishi Y; Taniguchi H; Sato K; Yamauchi M; Nakajima M; Takahashi K
Oncology; 2022; 100(11):620-632. PubMed ID: 36099876
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of absorption, metabolism, and excretion of 5-aminolevulinic acid in human intestinal Caco-2 cells.
Saito K; Fujiwara T; Ota U; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Ishizuka M; Tanaka T; Harigae H
Biochem Biophys Rep; 2017 Sep; 11():105-111. PubMed ID: 28955775
[TBL] [Abstract][Full Text] [Related]
18. 5-aminolevulinic acid combined with ferrous ion reduces adiposity and improves glucose tolerance in diet-induced obese mice via enhancing mitochondrial function.
Ota U; Hara T; Nakagawa H; Tsuru E; Tsuda M; Kamiya A; Kuroda Y; Kitajima Y; Koda A; Ishizuka M; Fukuhara H; Inoue K; Shuin T; Nakajima M; Tanaka T
BMC Pharmacol Toxicol; 2017 Jan; 18(1):7. PubMed ID: 28132645
[TBL] [Abstract][Full Text] [Related]
19. Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats.
Hara T; Koda A; Nozawa N; Ota U; Kondo H; Nakagawa H; Kamiya A; Miyashita K; Itoh H; Nakajima M; Tanaka T
FEBS Open Bio; 2016 Jun; 6(6):515-28. PubMed ID: 27239432
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro.
Ngwe Tun MM; Sakura T; Sakurai Y; Kurosaki Y; Inaoka DK; Shioda N; Smith C; Yasuda J; Morita K; Kita K
Trop Med Health; 2022 Apr; 50(1):30. PubMed ID: 35477500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
